SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CICCONE, Maria
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.519
AS - Asia 2.708
EU - Europa 1.521
SA - Sud America 375
Continente sconosciuto - Info sul continente non disponibili 73
AF - Africa 52
OC - Oceania 7
Totale 10.255
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.380
SG - Singapore 1.014
CN - Cina 747
DE - Germania 346
VN - Vietnam 317
BR - Brasile 281
IT - Italia 233
UA - Ucraina 208
GB - Regno Unito 183
HK - Hong Kong 169
TR - Turchia 142
FR - Francia 106
FI - Finlandia 103
BD - Bangladesh 91
CA - Canada 78
SE - Svezia 75
RU - Federazione Russa 71
JP - Giappone 63
IN - India 59
MX - Messico 42
PL - Polonia 40
AR - Argentina 28
CZ - Repubblica Ceca 26
ES - Italia 25
NL - Olanda 25
ID - Indonesia 22
BE - Belgio 21
IQ - Iraq 19
LT - Lituania 18
ZA - Sudafrica 18
EC - Ecuador 17
CO - Colombia 13
VE - Venezuela 13
CL - Cile 12
PK - Pakistan 10
RO - Romania 9
AT - Austria 8
EG - Egitto 7
MA - Marocco 7
MY - Malesia 7
SA - Arabia Saudita 7
IL - Israele 6
TT - Trinidad e Tobago 6
UZ - Uzbekistan 6
AU - Australia 5
KE - Kenya 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
ET - Etiopia 4
IR - Iran 4
KR - Corea 4
PY - Paraguay 4
BG - Bulgaria 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
IE - Irlanda 3
JM - Giamaica 3
OM - Oman 3
PH - Filippine 3
UY - Uruguay 3
AZ - Azerbaigian 2
BO - Bolivia 2
DZ - Algeria 2
HU - Ungheria 2
KG - Kirghizistan 2
LY - Libia 2
MT - Malta 2
NI - Nicaragua 2
PT - Portogallo 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
BB - Barbados 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DM - Dominica 1
EU - Europa 1
GF - Guiana Francese 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MK - Macedonia 1
NG - Nigeria 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RS - Serbia 1
RW - Ruanda 1
SR - Suriname 1
TO - Tonga 1
Totale 10.184
Salva come PNG Salva come JPEG
Città #
Singapore 670
Ashburn 641
Woodbridge 467
Fairfield 391
San Jose 388
Houston 320
Beijing 290
Chandler 259
Santa Clara 230
Jacksonville 224
Ann Arbor 179
Seattle 161
Hong Kong 160
Cambridge 148
Wilmington 137
Los Angeles 123
New York 123
Council Bluffs 108
Ho Chi Minh City 96
Munich 87
Dallas 83
Hanoi 74
Nanjing 71
Izmir 70
Tokyo 57
Princeton 54
Ferrara 51
Shanghai 50
Milan 44
Lauterbourg 41
Boardman 40
San Diego 40
São Paulo 39
Warsaw 38
Addison 37
Turku 32
Buffalo 27
Helsinki 26
London 26
Montreal 26
Shenyang 26
Bremen 25
Mexico City 23
Orem 23
Brussels 21
Toronto 21
Denver 20
Nanchang 20
Phoenix 20
Chicago 19
Frankfurt am Main 19
Haiphong 19
Manchester 19
Stockholm 19
Brooklyn 18
Da Nang 18
Poplar 18
Chennai 17
San Francisco 17
Hebei 15
Hefei 15
Johannesburg 15
Brno 14
Falkenstein 13
Tianjin 13
Amsterdam 12
Changsha 12
Elk Grove Village 12
Jinan 12
Bologna 11
Jakarta 11
Mumbai 11
Rio de Janeiro 11
Atlanta 10
Auburn Hills 10
Augusta 10
Boston 10
Guangzhou 10
Moscow 10
Olomouc 10
Zhengzhou 9
Baghdad 8
Biên Hòa 8
Orange 8
The Dalles 8
Ankara 7
Dearborn 7
Guayaquil 7
Hải Dương 7
Jiaxing 7
Madrid 7
Nuremberg 7
Ottawa 7
San Mateo 7
Philadelphia 6
Rome 6
Santiago 6
Can Tho 5
Charlotte 5
Curitiba 5
Totale 6.894
Salva come PNG Salva come JPEG
Nome #
Diagnostic work-up for clinical and prognostic assessment of acute leukaemia 298
Involvement of the P2X7-NLRP3 axis in leukemic cell proliferation and death 289
CYTOGENETIC ABERRATIONS IN THE CD38 POSITIVE FRACTION OF CD38 NEGATIVE CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS: A MARKER OF AGGRESSIVENESS? 280
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 272
Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy 268
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 266
Clonal evolution including 14q32/IGH translocations in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 264
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 260
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 260
Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients 254
Chromosome Aberrations by Conventional Karyotyping in Chronic Lymphocytic Leukemia Carrying No Aberration by Fluorescence in Situ Hybridization: Correlation with Prognostic Parameters and Clinical Features 252
Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival 250
Thrombosis of the cerebral veins and sinuses in acute promyelocytic leukemia after all-trans retinoic acid treatment: a case report. 249
In patients with myelodysplastic syndromes response to rHuEPO and G-CSF treatment is related to an increase of cytogenetically normal CD34+ cells 243
Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype 236
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS IN A PATIENT WITH RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA TREATED WITH IBRUTINIB 234
Neoplastic circulating endothelial cells in multiple myeloma with 13q14 deletion 233
A highly sensitive and specific fluorescence in situ hybridization (FISH) approach for the detection of t(9;11)(p22-23;q23) in acute myeloid leukemia. 227
Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: Correlations with clinicobiologic parameters 227
Identifying High-Risk Chronic Lymphocytic Leukemia: A Reappraisal of the Impact of Prognostic and Predictive Factors 225
Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation 218
Neoplastic circulating endothelial-like cells in patients with acute myeloid leukaemia 213
MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia 212
BCR/ABL1-positive acute lymphoblastic leukemia relapsing as BCR/ABL1-negative acute lymphoblastic leukemia 212
Dendritic cell recovery after allogeneic stem-cell transplantation in acute leukemia: Correlations with clinical and transplant characteristics 210
LATE APPEARANCE of 14q32/IGH TRANSLOCATION In CHRONIC LYMPHOCYTIC LEUKEMIA. 209
Hsa-miR-15a and Hsa-miR-16-1 expression is not related to proliferation centers abundance and other prognostic factors in chronic lymphocytic leukemia 207
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia” 207
Peripheral T-cell lymphoma not otherwise specified (PTCL-NOS) 206
Flow cytometric detection of accelerated telomere shortening in myelodysplastic syndromes: Correlations with aetiological and clinical-biological findings 206
CLINICAL AND BIOLOGICAL CHARACTERIZATION OF CIRCULATING ENDOTHELIAL CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA 198
Mobilization of endothelial progenitor cells in patientes with haematological malignancies after treatment with filgrastim and chemotherapy for autologous transplantation 197
Clonal evolution in chronic lymphocytic leukemia: analysis of clinicobiologic correlations in 105 patients 195
Neoplastic circulating endothelial cells in hematologic malignancies 187
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromes 182
Clinicobiologic importance of cytogenetic lesions in chronic lymphocytic leukemia 178
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays 177
IN CHRONIC LYMPHOCYTIC LEUKEMIA THE AMOUNT OF PROLIFERATION CENTERS IN TISSUE-BIOPSIES CORRELATES WITH UNFAVORABLE CYTOGENETIC ABNORMALITIES 163
Molecular cytogenetic lesions in chronic lymphocytic leukemia 161
Trisomy 8 in PDGFRB-negative cells in a patient with imatinib-sensitive chronic myelomonocytic leukemia and t(5;16)(q33;p13) PDGFRB-NDE1 fusion 159
Modern treatment in chronic lymphocytic leukemia: impact on survival and efficacy in high-risk subgroups. 157
Significato dell'analisi citogenetica e citogenetico-molecolare nella diagnosi e nella prognosi delle neoplasie ematologiche. Cytogenetics and molecular cytogenetics in diagnosis and prognosis of haematological malignancies 144
TRISOMY 8 IN PDGFRB-NEGATIVE CELLS IN A PATIENT WITH IMATINIB SENSITIVE CHRONIC MYELOMONOCYTIC LEUKAEMIA AND THE T(5;16)(Q33;P13)/PDGFRB/NDE1 FUSION 143
IFI16 reduced expression is correlated with unfavorable outcome in chronic lymphocytic leukemia 138
Neoplastic circulating endothelial cells in hematologic malignancies 136
Misinterpretation of an inflammatory FDG uptake in a patient treated for Hodgkin lymphoma: a case report 123
Neoplastic circulating endothelial cells in hematologic malignancies. 111
In vitro and ex vivo rescue of a nonsense mutation responsible for severe coagulation factor V deficiency 82
rHuEpo administration in patients with low-risk myelodysplastic syndromes: evaluation of erythroid precursors’ response by fluorescence in situ hybridization on May-Grunwald-Giemsa-stained bone marrow sample. 78
null 59
null 55
null 45
Totale 10.255
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.707
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 732
Totale 44.439
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022454 0 0 32 16 29 23 24 18 11 46 56 199
2022/2023562 55 31 24 69 111 73 31 55 60 5 26 22
2023/2024277 28 37 10 7 11 56 12 22 7 6 6 75
2024/20251.276 16 42 91 51 170 149 13 44 201 105 197 197
2025/20263.966 400 166 284 534 619 274 448 225 346 394 148 128
2026/2027398 91 195 112 0 0 0 0 0 0 0 0 0
Totale 10.255